ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced the presentation of ...

This important study advances a new computational approach to measure and visualize gene expression specificity across different tissues and cell types. The framework is potentially helpful for ...

ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced the presentation of ...

Genomics, Inc. , a leader in single cell and spatial biology, today announced Atera, a new in situ spatial biology platform engineered to deliver whole-transcriptome spatial analysis with single-cell ...

Takara Bio USA, Inc. today announced the launch of its CSP Program and announced the certification of Admera Health on the ...

As the “Method of the Year 2024”, spatial proteomics (SP) enables in situ characterization of protein localization, abundance ...

Increasing prevalence of bleeding disorders, rising number of surgical procedures, aging population, and growing focus on ...

Recursion Pharmaceuticals, Inc. (RXRX) 25th Annual Needham Virtual Healthcare Conference April 13, 2026 12:45 PM EDTCompany ParticipantsBen Taylor - ...

"RNA modifications are central to how cells respond to their environment," said Gudrun Stengel, Ph.D., Chief Executive Officer of Alida Biosciences. "With EpiPlex Tri-Mod, we move beyond method ...

Statistics show clear differences in the population's immune system according to sex: men are more susceptible to infections and cancers, while women have stronger immune responses, which translate, ...

AWS Social Impact and Sustainability Program awards Admera Health, Bringing Next-Generation Genomics to Underserved ...

Researchers say study lays groundwork for tailored sex-specific strategies to monitor and improve immune health across lifespan.